Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 12, 2006Journal of the American Society of Nephrology

Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

AEAllison A. EddyUniversity of British Columbia
Agnes B. Fogo
Agnes B. FogoUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Eddy et al. (2006) studied this question.

synapsesocial.com/papers/69d91062e6ab964fb083583chttps://doi.org/10.1681/asn.2006050503
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease2000 · 810 citations
  2. 2Chronic Hypoxia and Tubulointerstitial Injury2005 · 1,145 citations
  3. 3Regression of Glomerulosclerosis with High-Dose Angiotensin Inhibition Is Linked to Decreased Plasminogen Activator Inhibitor-12005 · 146 citations